Supporting Staff Through The Transition To Hybrid Studies

Up until the last decade, most clinical trials were conducted in person. Traditional clinical trials are slower, less efficient, and often more expensive than fully decentralized trials. These obstacles can lead to a lack of diversity among clinical trial participants, meaning that certain populations may not be accurately represented in the development of a drug or treatment.

In this blog, explore the benefits of decentralized trials as well as how you can support your staff through the transition to a hybrid or fully decentralized model.